Syringe with recessed nose and protective guard for use with frontal attachments

US9295790B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9295790-B2
Application numberUS-3063708-A
CountryUS
Kind codeB2
Filing dateFeb 13, 2008
Priority dateMay 5, 2006
Publication dateMar 29, 2016
Grant dateMar 29, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A medical device connectable to a frontal attachment, the medical device having a forwardly projecting fluid outlet member and a forwardly projecting protective guard extending beyond the outlet member to protect the outlet member from pathogenic contamination by contact prior to connection to the frontal attachment.

First claim

Opening claim text (preview).

The invention claimed is: 1. A syringe having an internal fluid path, said syringe comprising: a body comprising a barrel, a protective guard, an integral mounting structure, and a nose; and a plunger inserted into sliding engagement with the barrel; wherein the nose comprises a luer connection surface and is insertable into fluid communication with a frontal attachment and is releasably connectable to the frontal attachment; the protective guard comprising a substantially cylindrical collar extending continuously around a longitudinally extending portion of the nose, and a plurality of circumferentially spaced-apart guard elements projecting forwardly in closely spaced relation from the substantially cylindrical collar; wherein the guard elements have forwardly facing free ends that flare radially outward relative to the nose and the substantially cylindrical collar as the free ends of the guard elements extend away from the mounting structure; and wherein the nose projects forwardly beyond the substantially cylindrical collar and the free ends of the guard elements project forwardly beyond the nose to recess the nose relative to the free ends of the guard elements and protect the nose from pathogenic contamination by contact. 2. The syringe of claim 1 wherein the syringe is pre-filled and further comprises a fluid-tight sealing cap. 3. The syringe of claim 1 wherein the nose has an axial bore disposed inwardly of the luer connection surface. 4. The syringe of claim 3 in combination with a sealing cap or a safety cap. 5. The syringe of claim 1 wherein an entirety of each of the spaced-apart guard elements is outwardly inclined relative to the substantially cylindrical collar. 6. The syringe of claim 1 , wherein the mounting structure is disposed in fixed relation to the nose. 7. The syringe of claim 6 wherein at least part of the mounting structure is internally threaded. 8. The syringe of claim 1 wherein the mounting structure is unitarily made as part of the body. 9. The syringe of claim 1 wherein the mounting structure is configured to receive and secure the frontal attachment in fluid-tight engagement with the body. 10. The syringe of claim 9 wherein the nose projects forwardly beyond the mounting structure. 11. The syringe of claim 1 wherein the spaced-apart guard elements are separated by elongate spaces. 12. The syringe of claim 1 in combination with the frontal attachment. 13. The syringe of claim 12 wherein the frontal attachment is selected from the group consisting of a hypodermic needle assembly, a CLAVE® connector, a luer lock connector or other vascular access connector, and a luer-activated catheter hub. 14. The syringe of claim 13 wherein the frontal attachment is the hypodermic needle assembly further comprising at least one integrated needle safety component.

Assignees

Inventors

Classifications

  • A61M5/31Primary

    Details · CPC title

  • via the distal end of a syringe, i.e. syringe end for mounting a needle cannula · CPC title

  • Tube connectors; Tube couplings {(A61M39/02 takes precedence; connecting needles to syringes or hubs A61M5/34; connecting catheter tubes to hubs A61M25/0014)} · CPC title

  • A61M5/347Primary

    rotatable, e.g. bayonet or screw (A61M5/344 takes precedence) · CPC title

  • A61M39/26Primary

    Valves closing automatically on disconnecting the line and opening on reconnection thereof {(check valves A61M39/24)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9295790B2 cover?
A medical device connectable to a frontal attachment, the medical device having a forwardly projecting fluid outlet member and a forwardly projecting protective guard extending beyond the outlet member to protect the outlet member from pathogenic contamination by contact prior to connection to the frontal attachment.
Who is the assignee on this patent?
Shaw Thomas J, Zhu Ni, Wood Gary, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61M5/31. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).